Fig. 6
From: LCP1 correlates with immune infiltration: a prognostic marker for triple-negative breast cancer
Predictive value of LCP1 in immunotherapy. A Analysis of correlations between LCP1 expression and various immune checkpoint genes. B-E Comparison of the Immune Phenotype Score (IPS) distributions, differentiated by CTLA-4 or PD-1 status, in high vs. low LCP1 expression groups within the TCGA-TNBC cohort. F Kaplan–Meier survival analysis showing the impact of LCP1 expression levels on overall survival in cancer patients treated with anti-PD-1 therapy. G Kaplan–Meier survival analysis for overall survival based on LCP1 expression in patients receiving anti-PD-L1 therapy. H Kaplan–Meier survival analysis for overall survival depending on LCP1 expression in patients treated with anti-CTLA-4 therapy